The University of Chicago Header Logo

Connection

Carrie W. Rinker-Schaeffer to Prostatic Neoplasms

This is a "connection" page, showing publications Carrie W. Rinker-Schaeffer has written about Prostatic Neoplasms.
  1. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Int J Cancer. 2012 Feb 01; 130(3):509-20.
    View in: PubMed
    Score: 0.170
  2. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Mol Cancer Res. 2008 Mar; 6(3):501-8.
    View in: PubMed
    Score: 0.137
  3. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia. J Pathol. 2007 Aug; 212(4):386-94.
    View in: PubMed
    Score: 0.132
  4. Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12. Int J Cancer. 2004 Jan 01; 108(1):15-22.
    View in: PubMed
    Score: 0.103
  5. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 2001 Apr 01; 61(7):2833-7.
    View in: PubMed
    Score: 0.085
  6. Metastasis suppression in prostate cancer. Cancer Metastasis Rev. 2001; 20(3-4):279-86.
    View in: PubMed
    Score: 0.083
  7. Defining the biologic role of genes that regulate prostate cancer metastasis. Curr Opin Urol. 2000 Sep; 10(5):397-401.
    View in: PubMed
    Score: 0.082
  8. The Dunning model. Prostate. 2000 Jun 01; 43(4):295-302.
    View in: PubMed
    Score: 0.080
  9. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 1999 Nov 01; 59(21):5483-7.
    View in: PubMed
    Score: 0.077
  10. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res. 1998 Nov 01; 58(21):4963-9.
    View in: PubMed
    Score: 0.072
  11. Identification of a novel metastasis-suppressor region on human chromosome 12. Cancer Res. 1998 Aug 15; 58(16):3561-5.
    View in: PubMed
    Score: 0.071
  12. Prostate cancer metastasis-suppressor genes: a current perspective. In Vivo. 1998 Jan-Feb; 12(1):49-58.
    View in: PubMed
    Score: 0.068
  13. Localization of prostate cancer metastasis-suppressor activity on human chromosome 17. Prostate. 1997 Dec 01; 33(4):271-80.
    View in: PubMed
    Score: 0.067
  14. The role of motility proteins and metastasis-suppressor genes in prostate cancer progression. Stem Cells. 1996 Sep; 14(5):508-16.
    View in: PubMed
    Score: 0.062
  15. Development of a high-efficiency method for gene marking of Dunning prostate cancer cell lines with the enzyme beta-galactosidase. Prostate. 1996 Jul; 29(1):60-4.
    View in: PubMed
    Score: 0.061
  16. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res. 1994 Dec 01; 54(23):6249-56.
    View in: PubMed
    Score: 0.055
  17. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate. 1994 Nov; 25(5):249-65.
    View in: PubMed
    Score: 0.054
  18. Molecular and cellular markers for metastatic prostate cancer. Cancer Metastasis Rev. 1993 Mar; 12(1):3-10.
    View in: PubMed
    Score: 0.048
  19. FYN is overexpressed in human prostate cancer. BJU Int. 2009 Jan; 103(2):171-7.
    View in: PubMed
    Score: 0.036
  20. Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells. J Urol. 2004 Dec; 172(6 Pt 2):2539-44.
    View in: PubMed
    Score: 0.027
  21. The basic biology of metastasis. Cancer Treat Res. 2004; 118:1-21.
    View in: PubMed
    Score: 0.026
  22. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol. 2003 Mar; 169(3):1122-33.
    View in: PubMed
    Score: 0.024
  23. Highlights of the Society of Urologic Oncology meeting, June 2, 2001. J Urol. 2002 Aug; 168(2):653-9.
    View in: PubMed
    Score: 0.023
  24. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent. Acad Radiol. 2002 May; 9 Suppl 1:S115-8.
    View in: PubMed
    Score: 0.023
  25. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med. 2001 Jun; 45(6):1046-55.
    View in: PubMed
    Score: 0.021
  26. Mapping of metastasis suppressor genes for prostate cancer by microcell-mediated chromosome transfer. Asian J Androl. 2000 Sep; 2(3):167-71.
    View in: PubMed
    Score: 0.020
  27. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med. 2000 May; 43(5):633-9.
    View in: PubMed
    Score: 0.020
  28. Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. Cancer Res. 1998 Oct 15; 58(20):4572-6.
    View in: PubMed
    Score: 0.018
  29. Workgroup I: rodent models of prostate cancer. Prostate. 1998 Jun 15; 36(1):49-55.
    View in: PubMed
    Score: 0.017
  30. Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother Pharmacol. 1998; 41(6):505-12.
    View in: PubMed
    Score: 0.017
  31. Prostate cancer--biology of metastasis and its clinical implications. World J Urol. 1996; 14(3):182-9.
    View in: PubMed
    Score: 0.015
  32. Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer. 1995 Oct; 14(2):112-9.
    View in: PubMed
    Score: 0.014
  33. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995 May 12; 268(5212):884-6.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.